PolarityTE Inc
NASDAQ:PTE
Intrinsic Value
PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. [ Read More ]
The intrinsic value of one PTE stock under the Base Case scenario is 0.0631 USD. Compared to the current market price of 0.0666 USD, PolarityTE Inc is Overvalued by 5%.
Valuation Backtest
PolarityTE Inc
Run backtest to discover the historical profit from buying and selling PTE stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
PolarityTE Inc
Current Assets | 8.9m |
Cash & Short-Term Investments | 6.4m |
Receivables | 446k |
Other Current Assets | 2.1m |
Non-Current Assets | 9.1m |
PP&E | 8.2m |
Other Non-Current Assets | 911k |
Current Liabilities | 2.2m |
Accounts Payable | 244k |
Accrued Liabilities | 1.5m |
Other Current Liabilities | 414k |
Non-Current Liabilities | 3.5m |
Other Non-Current Liabilities | 3.5m |
Earnings Waterfall
PolarityTE Inc
Revenue
|
73k
USD
|
Cost of Revenue
|
-125k
USD
|
Gross Profit
|
-52k
USD
|
Operating Expenses
|
-21.9m
USD
|
Operating Income
|
-21.9m
USD
|
Other Expenses
|
13.6m
USD
|
Net Income
|
-8.3m
USD
|
Free Cash Flow Analysis
PolarityTE Inc
PTE Profitability Score
Profitability Due Diligence
PolarityTE Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
Score
PolarityTE Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
PTE Solvency Score
Solvency Due Diligence
PolarityTE Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
PolarityTE Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PTE Price Targets Summary
PolarityTE Inc
Ownership
PTE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PTE Price
PolarityTE Inc
Average Annual Return | -50% |
Standard Deviation of Annual Returns | 37.68% |
Max Drawdown | -100% |
Market Capitalization | 740k USD |
Shares Outstanding | 11 110 443 |
Percentage of Shares Shorted | 1.69% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The company is headquartered in Salt Lake City, Utah and currently employs 59 full-time employees. The firm is focused on developing regenerative tissue products and biomaterials. The company also operates a laboratory testing and clinical research business using equipment, personnel, and facilities it acquired to advance its development of regenerative tissue products. Its first regenerative tissue product is SkinTE, which is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The firm's development projects include SkinTE Cryo, SkinTE point-of-care device, PTE 11000, and others.
Contact
IPO
Employees
Officers
The intrinsic value of one PTE stock under the Base Case scenario is 0.0631 USD.
Compared to the current market price of 0.0666 USD, PolarityTE Inc is Overvalued by 5%.